Suppr超能文献

术前控制营养状况(CONUT)评分作为术前影像学检查≤7cm 非转移性透明细胞肾细胞癌患者生存的新型免疫营养预测因子。

Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.

机构信息

Department of Urology and Urological Science Institute, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea.

Department of Urology, Tanta University College of Medicine, Tanta, 31512, Egypt.

出版信息

J Cancer Res Clin Oncol. 2019 Apr;145(4):957-965. doi: 10.1007/s00432-019-02846-x. Epub 2019 Feb 13.

Abstract

PURPOSE

This study aimed at investigating the prognostic value of Preoperative controlling nutritional status (CONUT) score in non-metastatic clear-cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.

METHODS

We retrospectively included 1046 among 1637 patients who underwent radical or partial nephrectomy for solid renal masses ≤ 7 cm (2005-2014) after excluding other pathology, conditions affecting CONUT score components, metastasis, regional lymphadenopathy, positive margin, and follow-up < 12 months. We defined high and low CONUT according to cut-off of (2). Multivariate Cox-regression analysis was used to predict factors affecting recurrence and survival. Kaplan-Meier curve was used for survival analysis.

RESULTS

The median age and follow-up were 56 years and 63 months, respectively. 41 patients had recurrence (3.9%). CONUT was a predictor for recurrence-free, cancer-specific, and overall survival (HR 3.09, P = 0.003 and HR 4.66, P = 0.004 and HR 2.81, P = 0.003, respectively). A higher CONUT was significantly associated with worse 5 years recurrence-free (88.2% vs. 97.1%), cancer-specific (96.2% vs. 98.8%) and overall (90.9% vs. 96.5%) survival (log-rank, P = < 0.001, P = 0.006 and P = < 0.001, respectively).

CONCLUSIONS

The preoperative CONUT is an independent prognostic marker for survival after curative surgery for non-metastatic clear-cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.

摘要

目的

本研究旨在探讨术前控制营养状况(CONUT)评分对术前影像学检查≤7cm 局限性透明细胞肾细胞癌的预后价值。

方法

我们回顾性纳入了 2005 年至 2014 年间 1637 例接受根治性或部分肾切除术治疗的直径≤7cm 实性肾肿块患者中的 1046 例(排除其他病理学、影响 CONUT 评分成分的情况、转移、区域淋巴结病、阳性切缘和随访<12 个月)。我们根据(2)的截断值将 CONUT 分为高和低。多变量 Cox 回归分析用于预测影响复发和生存的因素。Kaplan-Meier 曲线用于生存分析。

结果

中位年龄和随访时间分别为 56 岁和 63 个月。41 例患者复发(3.9%)。CONUT 是无复发生存、癌症特异性生存和总生存的预测因素(HR 3.09,P=0.003 和 HR 4.66,P=0.004 和 HR 2.81,P=0.003)。较高的 CONUT 与较差的 5 年无复发生存率(88.2%比 97.1%)、癌症特异性生存率(96.2%比 98.8%)和总生存率(90.9%比 96.5%)显著相关(log-rank,P<0.001、P=0.006 和 P<0.001)。

结论

术前 CONUT 是术前影像学检查≤7cm 局限性透明细胞肾细胞癌根治术后生存的独立预后标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验